Related Experiment Video

Updated: May 7, 2026

Myo-mechanical Analysis of Isolated Skeletal Muscle
08:42

Myo-mechanical Analysis of Isolated Skeletal Muscle

Published on: February 23, 2011

Molecular mechanisms of muscle atrophy

Iain W McKinnell1, Michael A Rudnicki

  • 1Ottawa Health Research Institute, 501 Smyth Road, Ottawa, Ontario K1H 8L6, Canada.

Cell
|December 29, 2004
PubMed

Insights

Molecular mechanisms of skeletal muscle atrophy are poorly understood. Recent research suggests the ubiquitin proteasome system plays a key role in various forms of muscle wasting.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Physiology

Background:

  • Skeletal muscle atrophy leads to severe adverse health outcomes.
  • The precise molecular pathways driving muscle atrophy remain largely undefined.
  • Emerging evidence points to the ubiquitin proteasome system's involvement in atrophy.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying skeletal muscle atrophy.
  • To investigate the role of ubiquitin ligases in mediating muscle wasting.
  • To identify common pathways across different atrophic stimuli.

Main Methods:

  • Review of recent molecular studies on muscle atrophy.
  • Analysis of signaling cascades controlling ubiquitin ligase activation.
  • Examination of the ubiquitin proteasome pathway in atrophic conditions.

Main Results:

  • Diverse molecular cascades are implicated in muscle atrophy.
  • Ubiquitin ligase activation is a central event in these cascades.
  • The ubiquitin proteasome pathway appears to be a common mediator of atrophy.

Conclusions:

  • The ubiquitin proteasome system is a significant factor in skeletal muscle atrophy.
  • Understanding these molecular mechanisms is crucial for developing interventions.
  • Further research into ubiquitin ligase regulation is warranted.

More Related Videos

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles14:02

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles

Published on: November 1, 2012

Immunolabelling Myofiber Degeneration in Muscle Biopsies06:37

Immunolabelling Myofiber Degeneration in Muscle Biopsies

Published on: December 5, 2019

Related Concept Videos

Cross-bridge Cycle01:26

Cross-bridge Cycle

As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Muscle Recovery and Fatigue01:24

Muscle Recovery and Fatigue

Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective response...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Cellular Adaptation I: Introduction and Atrophy01:23

Cellular Adaptation I: Introduction and Atrophy

Cells can adapt to environmental changes to maintain function and avoid injury, a process called cellular adaptation. Adapted cells exist in a reversible intermediate state with changes in size, number, phenotype, metabolism, or function. These responses help cells meet altered physiological or pathological demands; for example, enlargement of breast and uterine tissues during pregnancy. Early adaptations may enhance function, but persistent stress eventually causes tissue damage.Types of...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...